Novartis | Beneficio Operativo



Operating Profit Cambio Fecha
AbbVie USD 3.73B 5.22B 2025-03
Alcon AG USD 468M 73M 2025-03
Almirall EUR 43.02M 8.82M 2025-06
Amgen USD 1.29B 1.02B 2025-03
AstraZeneca USD 3.67B 1.64B 2025-03
Autolus Therapeutics Ltd -65240000 10.62M 2025-03
Bayer EUR 2.32B 1.21B 2025-03
Biogen USD 311.2M 130.2M 2025-03
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
Eli Lilly USD 5.41B 259.6M 2025-03
Fresenius EUR 687M 218M 2025-03
Fresenius Medical Care EUR 331M 72.1M 2025-03
Galapagos EUR -57027000 101.68M 2025-06
Genmab DKK 188M 2B 2025-03
Gilead Sciences USD 2.24B 215M 2025-03
GlaxoSmithKline GBP 2.22B 1.52B 2025-03
GRIFOLS EUR 268.86M 103M 2025-03
Hikma Pharmaceutical USD 282M 45M 2024-12
J&J USD 6.94B 6.69B 2025-06
Lonza CHF 430M 104M 2024-12
Merck EUR 1.01B 189M 2025-03
Merck USD 5.87B 1.57B 2025-03
Novartis USD 4.86B 201M 2025-06
Novartis USD 3.4B 193M 2024-12
Novo Nordisk 38.79B 4.97B 2025-03
Orion EUR 104.6M 26.7M 2025-06
Pfizer USD 3.67B 4.08B 2025-03
Philips EUR 154M 45M 2025-03
Recordati EUR 195.77M 33.09M 2025-03
Regeneron Pharmaceuticals USD 591.7M 398.5M 2025-03
Roche Holding CHF 4.39B 1.04B 2024-12
Sanofi EUR 2.28B 1.42B 2025-03
UCB EUR 1B 678M 2024-12


Novartis Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Jul 2025.